Biomaterial Database

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

Department of Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.

UI	MeSH Term	Description	Entries
D009705	Nucleosides	Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)	Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D003521	Cyclopropanes	Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D000225	Adenine	A purine base and a fundamental unit of ADENINE NUCLEOTIDES.	Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000998	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.	Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329	Structure-Activity Relationship	The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.	Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

January 2023, Nucleosides, nucleotides & nucleic acids,

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

January 2006, Current medicinal chemistry,

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

January 2021, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

January 1999, Nucleic acids symposium series,

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

May 2013, Bioorganic & medicinal chemistry letters,

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

January 1997, Nucleic acids symposium series,

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

May 2024, Molecules (Basel, Switzerland),

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

January 2008, Bioorganicheskaia khimiia,

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

April 1984, Chemical & pharmaceutical bulletin,

T Watanabe, and S Ueki, and T Nobukuni, and S Nishiyama, and S Yamamura, and K Kato, and M Nagai, and T Takita

January 1979, Nucleic acids symposium series,